Clinical Trial Update: An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED) [Phase 2, Phase 3]

View source ↗

Summary

An eighteen-month efficacy and safety study in obese patients (0364-020) has completed (Phase 2/3). It was sponsored by Merck Sharp & Dohme LLC; the snippet doe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity and Obesity-related Medical Conditions | Phase 2, Phase 3 | Status: COMPLETED